Study: Sinopharm's booster jab ineffective against Omicron variant of the COVID-19
According to a recent Chinese study involving 292 samples, the Sinopharm vaccine jab is weak against the Omicron variant of COVID-19.
According to a recent Chinese study involving 292 samples, the Sinopharm vaccine jab is weak against the Omicron variant of COVID-19.